Alpex Acquisition Corp 8-K

What Happened
Alpex Acquisition Corp filed an 8‑K reporting the closing of its initial public offering (IPO) and related corporate actions. On June 26, 2026 the company sold 11,500,000 units at $10.00 per unit (including full exercise of a 1,500,000 unit overallotment), and substantially concurrently sold 187,500 private units to its sponsor, Hugreat Ltd. A total of $115,000,000 from the IPO and private sale (after transaction expenses and working capital) was placed in the company’s trust account. The company also named three independent directors — “Joy” Yi Hua, Xin Yue Jasmine Geffner (designated audit committee chair and audit committee financial expert), and Yuanmei Ma — effective June 25, 2026.

Key Details

• IPO: 11,500,000 Units at $10.00 each = gross proceeds from the public offering of $115,000,000 (includes 1,500,000 unit overallotment). Each Unit = 1 Class A ordinary share, 1 warrant (exercise price $11.50), and 1 right (one-fourth of a share upon business combination).
• Private sale: 187,500 Private Units sold to Sponsor (Hugreat Ltd) for $1,875,000 (exempt from registration under Section 4(a)(2)).
• Underwriting / trustee items: 230,000 Class A ordinary shares issued to D. Boral Capital LLC as underwriting compensation; $115,000,000 placed in trust and will be released only upon completion of an initial business combination, certain shareholder votes, or required redemptions if no combination is completed within the stated period.
• Governance: Amended and Restated Memorandum and Articles adopted (effective on listing); Sponsor transferred 20,000 Class A shares to each new director at approximately $0.01 per share; Representative agreed to 180‑day transfer restrictions and to waive certain redemption and liquidation rights for its shares.

Why It Matters
This filing confirms Alpex’s SPAC capital structure: cash raised and held in a trust specifically to fund a future business combination, investor redemption rights, and a one‑year timeline (as set in its charter) governing completion or wind‑down. The appointment of independent directors — including an audit committee financial expert as chair — and the sponsor/representative share restrictions are relevant to governance, potential selling pressure, and how the company will pursue and evaluate acquisition targets. Investors should watch the trust account, the SPAC’s timeline for a business combination, and any future proxy or deal announcements.